XTalks

JANUARY 28, 2022

Uveal melanoma is a rare and aggressive type of melanoma of the eye. Up to 50 percent of patients will develop metastatic disease, mainly spreading to the liver, making treatment difficult and limited. The new treatment will thus help address the unmet need for the disease. The median treatment time is about 23 weeks (or 5.3

FDA Approval 98

FDA Approval Development Licensing Licensing 98

Intouch Solutions

APRIL 11, 2024

This can make a difference in all cases, but particularly with rare diseases. Offering the physician support from a virtual assistant during the differential diagnosis process where they have access to a more extensive knowledge and experience base.

Compliance 52

Compliance Marketing Drugs Pharma Companies 52

XTalks

MARCH 22, 2023

The years that followed have seen a rise in large pharma companies acquiring much smaller biopharmas with a narrow focus on rare disease therapeutic development. Click on the infographic to explore the data. And a decade earlier, in 2002, Pfizer’s Lipitor (atorvastatin calcium) reigned supreme.

Life Science 97

Life Science Drugs FDA Approval Vaccination 97

Pharmaceutical Technology

JANUARY 27, 2023

On January 18, Sanofi launched a new warranty program for its rare blood disorder drug Cablivi (caplacizumab), which tackles value-based agreements in a slightly different way. A refund up to 12 inpatient doses will also be offered for patients whose disease worsens while receiving treatment.

Manufacturing 130

Manufacturing Drugs Research Analyst FDA Approval 130